
Alkem Laboratories Limited has informed the Exchange about press release dated 14-Apr-2022 titled US FDA Inspection at Alkem���s Bioequivalence Center at Taloja.
Filed with NSE ·

Alkem Laboratories Limited has informed the Exchange about press release dated 14-Apr-2022 titled US FDA Inspection at Alkem���s Bioequivalence Center at Taloja.
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories